George Hruby

Prospective Comparison of ¹⁸ F-Fluoromethylcholine Versus ⁶⁸ Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy

Joshua James Morigi, Phillip D. Stricker, Pim J. van Leeuwen et al. · Journal of Nuclear Medicine · 2015 · 567 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The Impact of ⁶⁸Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study

Paul Roach, Roslyn J. Francis, Louise Emmett et al. · Journal of Nuclear Medicine · 2017 · 365 citations · Full text

Medicine, Oncology, Radiology +17

Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical Progression

Richard Choo, Laurence Klotz, Cyril Danjoux et al. · The Journal of Urology · 2002 · 359 citations

Medicine, Oncology, Urology +17

UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas

Stephen Q. Wong, Kelly Waldeck, Ismael A. Vergara et al. · Cancer Research · 2015 · 327 citations

Life Sciences, Genetics, Oncology +17

⁶⁸ Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment

Pim J. van Leeuwen, Phillip D. Stricker, George Hruby et al. · British Journal of Urology · 2015 · 254 citations

Medicine, Nuclear Medicine, Radiation Oncology +17